Dirithromycin
Alternative Names: ASE 136; Divitross; Dynabac; LY 237216; Noriclan; Nortron; ValodinLatest Information Update: 24 Oct 2021
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Antibacterials; Macrolides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Pneumonia; Respiratory tract infections; Skin and soft tissue infections
Most Recent Events
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 30 Mar 2000 Muro Pharmaceutical has been acquired by ASTA Medica
- 27 Aug 1999 Sanofi has merged with Synthélabo to form Sanofi-Synthélabo